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Abstract
Although certain risk factors have been associated with morbidity and mortality, validated emergency department (ED)
derived risk prediction models specific to coronavirus disease 2019 (COVID-19) are lacking. The objective of this study is
to describe and externally validate the COVID-19 risk index (CRI). A large retrospective longitudinal cohort study was performed to analyze consecutively hospitalized patients with COVID-19. Multivariate regression using clinical data elements
from the ED was used to create the CRI. The results were validated with an external cohort of 1799 patients from the MICOVID19 database. The primary outcome was the composite of the need for mechanical ventilation or inpatient mortality,
and the secondary outcome was inpatient mortality. A total of 1020 patients were included in the derivation cohort. A total of
236 (23%) patients in the derivation cohort required mechanical ventilation or died. Variables independently associated with
the primary outcome were age ≥ 65 years, chronic obstructive pulmonary disease, chronic kidney disease, cerebrovascular
disease, initial D-dimer > 1.1 µg/mL, platelet count < 150 K/µL, and severity of SpO2:FiO2 ratio. The derivation cohort had
an area under the receiver operator characteristic curve (AUC) of 0.83, and 0.74 in the external validation cohort Calibration
shows close adherence between the observed and expected primary outcomes within the validation cohort. The CRI is a
novel disease-specific tool that assesses the risk for mechanical ventilation or death in hospitalized patients with COVID-19.
Discrimination of the score may change given continuous updates in contemporary COVID-19 management and outcomes.
Keywords COVID-19 · Risk score · Outcomes · Risk factors · SARS-CoV-2
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Highlights
• Although certain risk factors have been associated with

morbidity and mortality in patients with Coronavirus
disease 2019 (COVID-19), emergency department (ED)
derived risk prediction models specific to COVID-19 are
lacking.
• The CRI is an accurate and validated risk prediction tool
scoring system that uses clinical data upon presentation
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to the ED to predict the need for mechanical ventilation
or inpatient death.
• Variables independently associated with the primary outcome were age ≥ 65 years, chronic obstructive pulmonary disease, chronic kidney disease, cerebrovascular disease, initial D-dimer > 1.1 µg/mL, platelet count < 150 K/
µL, and severity of SpO2:FiO2 ratio.
• The CRI can guide early triage, inform treatment strategies, and empower physician decision-making during the
COVID-19 pandemic.

Introduction
Coronavirus disease 2019 (COVID-19) is caused by the
novel severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2), which was first identified in Wuhan, China,
in December 2019, and has since caused a global pandemic
[1].
The clinical manifestations of COVID-19 vary from
asymptomatic to severe disease [2]. In a multicenter case
series from New York, 14% of discharged patients required
ICU admission [3], with high inpatient mortality [3]. Data
so far has demonstrated that underlying comorbid conditions, inflammatory markers, and hypoxic respiratory failure
are associated with a higher incidence of adverse outcomes,
including mechanical ventilation and mortality [3–6].
During a pandemic, a mass influx of patients can quickly
exhaust available resources overwhelming an entire healthcare system. Under such circumstances, a simple risk model
that can accurately predict patient outcomes would be valuable in determining early prognosis and aid in triaging
patients presenting to the emergency department (ED). Multiple risk models have been described, but to our knowledge,
no large study has been externally validated.
Herein, we describe the characteristics and findings of
patients hospitalized for COVID-19 at a tertiary care healthcare system. Our study aimed to develop the COVID-19 risk
index (CRI): a pragmatic tool to assess the risk for requiring
mechanical ventilation or death upon presentation to the ED.
We also aimed to validate the risk model within a larger
38-center external hospital registry.

Materials and methods
Derivation cohort patient population
We analyzed the records of patients consecutively admitted
to Henry Ford Health System in Southeast Michigan between
March and May 2020. Patients selected were ≥ 18 years of
age and were hospitalized with a confirmed SARS-CoV-2
diagnosis. Patients were excluded if they were transferred
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to or out of our center or developed cardiac arrest prior to
presentation. Records were reviewed retrospectively.
SARS-CoV-2 was diagnosed by onsite molecular diagnostic testing for the identification of SARS-CoV-2 RNA
using reverse transcription polymerase chain reaction (RTPCR). Our method has been validated against the Centers
for Disease Control and Prevention (CDC) reference method
to meet or exceed the level of detection required under Food
and Drug Administration (FDA) Emergency Use Authorization (EUA) guidelines.

Definition of outcomes
The primary outcome was a composite of the need for
mechanical ventilation or death during hospitalization. The
secondary outcome was inpatient mortality.

Definitions of variables and predictor selection
Variables measured at hospital admission (Table 1) were
collected at hospital admission. These variables included
demographics, symptoms on admissions, vital signs, comorbidities, laboratory, and radiologic data obtained on admission. Data collection was manually extracted from electronic health records. Symptoms were deemed positive if
endorsed within 24 h of presentation. Laboratory data were
manually extracted. Baseline results refer to initial blood
samples collected in the ED or the first values within 24 h
of admission. Comorbid conditions were identified based
on admission and discharge diagnoses. This study was
approved by the Institutional Review Board (IRB #13774),
with a waiver of informed consent. Serum ferritin, D-dimer,
creatinine phosphokinase, high-sensitivity troponin-I, and
lactate dehydrogenase level cutoffs were used based on the
median. Lymphopenia was defined as an absolute lymphocyte count < 1000 counts/uL [7], and anemia as a hemoglobin level < 11 g/dL. Troponin levels were categorized
according to the upper 99th percentile as per prior work
[8]. Immunosuppression was defined as a history of autoimmune disease, immunodeficiency disorders, transplantation, immunosuppressant use (any disease-modifying agent
or prednisone ≥ 10 mg or equivalent for more than 14 days),
human immunodeficiency virus, or active malignancy. Cardiovascular disease was defined as any coronary artery disease, heart failure, or cardiac arrhythmia. Peripheral capillary oxygen saturation (SpO2) values were obtained from
pulse oximetry vital logs. For patients not on mechanical
ventilation, the fraction of inspired oxygen ( FiO2) was estimated by multiplying liter flow per minute by 0.03 and adding that to 0.21, in accordance with original mSOFA investigations [9]. SpO2:FiO2 ratios were categorized similarly
to the Berlin criteria for acute respiratory distress syndrome
[10]. Data regarding mean arterial pressure, supplemental
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Table 1  Clinical characteristics of patients on presentation from the derivation cohort
Variable

Primary Outcome

P value

Mechanical Ventilation or Death

Total No. of observations (%)
I. Demographic characteristic
Age (years), Median
≥ 65
Gender
Female—No. (%)
Male—No. (%)
Race—No. (%)
White
Black
Body mass index
II. Vital signs and oxygenation on admission
Mean arterial pressure (mmHg)
SPO2:FiO2 Ratio
> 400
> 300 to ≤ 400
> 200 to ≤ 300
> 100 to ≤ 200
≤ 100
III. Symptoms on admission
Chest pain
Fever
Cough
Shortness of breath
GI symptoms
IV. Comorbid conditions
Hypertension
Diabetes mellitus
Cerebrovascular disease
Coronary artery disease
Heart failure
Atrial fibrillation/flutter
Chronic kidney disease
Smoking history
Chronic obstructive pulmonary disease
Obstructive sleep apnea
Asthma
Chronic hypoxic respiratory failure
Immunosuppression
Cirrhosis
V. Medications
Anticoagulant
ACEi/ARB
Insulin
Statin

Overall
N (%)

With
N (%)

Without
N (%)

1020

236

784

63 (51–73)
471 (46%)

72 (62–81)
160 (68%)

60 (50–70)
311 (40%)

< 0.001
< 0.001

511 (50%)
509 (50%)

101 (42%)
135 (57%)

410 (52%)
374 (48%)

0.011

403 (40%)
463 (45%)
31 (26–37)

80 (34%)
117 (50%)
30 (26–36)

323 (41%)
346 (44%)
32 (27–37)

0.132

88 (78–98)
339
(267–452)
419 (42%)
245 (24%)
231 (23%)
85 (8%)
40 (4%)

83 (74–93)
247
(140–330)
38 (16%)
40 (17%)
71 (31%)
50 (21%)
36 (15%)

88 (78–98)
394
(303–457)
381 (49%)
205 (26%)
159 (20%)
35 (5%)
4 (1%)

Reference
0.006
< 0.001
< 0.001
< 0.001

156 (15%)
539 (53%)
679 (67%)
686 (67%)
366 (36%)

24 (10%)
102 (43%)
141 (60%)
167 (71%)
58 (25%)

132 (17%)
437 (56%)
538 (69%)
519 (66%)
308 (39%)

0.013
< 0.001
0.011
0.190
< 0.001

742 (73%)
453 (44%)
80 (8%)
123 (12%)
127 (13%)
66 (6%)
309 (30%)
361 (35%)
105 (10%)
90 (9%)
104 (10%)
30 (3%)
155 (15%)
8 (1%)

193 (82%)
122 (52%)
40 (17%)
45 (19%)
46 (20%)
33 (14%)
117 (50%)
107 (45%)
42 (18%)
21 (9%)
17 (7%)
15 (6%)
52 (22%)
4 (2%)

549 (70%)
331 (42%)
40 (5%)
79 (10%)
81 (10%)
33 (4%)
192 (25%)
254 (32%)
63 (8%)
69 (9%)
87 (11%)
15 (2%)
103 (13%)
4 (1%)

< 0.001
0.010
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
0.963
0.083
< 0.001
0.001
0.071

96 (9%)
361 (35%)
158 (16%)
428 (42%)

35 (15%)
86 (36%)
51 (23%)
107 (45%)

61 (8%)
275 (35%)
107 (14%)
321 (41%)

0.001
0.701
0.001
0.230

0.069
< 0.001
< 0.001
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Table 1  (continued)
Variable

Primary Outcome

P value

Mechanical Ventilation or Death

V. Laboratory data
Sodium (mmol/L)
Potassium (mmol/L)
Creatinine (mg/dL)
White blood cell count (K/µL)
Lymphocytes (K/µL)
Hemoglobin (g/dL)
Anemia
Platelet count (K/µL)
Thrombocytopenia
Alanine aminotransferase (IU/L)
Aspartate aminotransferase (IU/L)
Total bilirubin (mg/dL)
Albumin (mg/dL)
Lactate dehydrogenase (IU/L)
Ferritin (ng/mL)
D-dimer (µg/mL)
High sensitivity troponin-I (ng/L)
Cardiac injury
VI. Chest imaging findings
Normal
Unilateral pneumonia
Bilateral pneumonia
Multi-focal pneumonia

Overall
N (%)

With
N (%)

Without
N (%)

136 (133–138)

135 (133–138)

< 0.001

3.9 (3.6–4.4)
1.12 (0.84–1.78)
6.4 (4.7–8.9)
0.9 (0.6–1.2)
13.0 (11.7–14.3)
283 (28%)
202 (155–271)
232 (23%)
23.5 (15–38)
36 (25–57)
0.6 (0.4–0.8)
3.5 (3.2–3.8)
348 (259–472)
519 (257–1050)
1.30 (0.73–2.46)
17 (6–32)
390 (38%)

136
(133–138)
4.1 (3.7–4.6)
1.48 (1.04–2.46)
7 (5.3–10.0)
0.8 (0.5–1.1)
12.7 (11.3–14.2)
84 (36%)
181 (140–252)
73 (31%)
25 (16–37)
45 (30–74)
0.6 (0.4–0.9)
3.3 (2.9–3.6)
418 (294–569)
680 (313–1426)
2.11 (1.20–3.75)
28 (14–75)
150 (63%)

3.9 (3.5–4.3)
1.07 (0.83–1.61)
6.2 (4.6–8.6)
0.9 (0.6–1.2)
13.1 (11.9–14.4)
199 (25%)
205 (157–271)
159 (20%)
23 (15–38)
35 (24–54)
0.6 (0.4–0.8)
3.6 (3.3–3.8)
336 (256–447)
483 (241–950)
1.12 (0.63–2.13)
13 (5–24)
240 (31%)

< 0.001
0.003
0.032
0.610
0.003
0.002
0.001
0.001
0.123
< 0.001
0.734
< 0.001
0.063
0.001
< 0.001
0.003
< 0.001

144 (14%)
135 (13%)
224 (22%)
517 (51%)

25 (11%)
30 (13%)
53 (23%)
128 (54%)

119 (15%)
105 (13%)
171 (22%)
389 (50%)

Reference
0.309
0.150
0.064

ACEi angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers

oxygen delivery, and Glasgow Coma Scale were ascertained
from ED vital logs.
A univariate analysis was performed, and the variables
that were significantly associated with our primary outcome
were included in logistic regression. The variables that
remained statistically associated (P ≤ 0.05) with the primary
outcome after multivariable regression were used to create
the CRI index.

Statistical analysis
Statistical Package for Social Sciences (SPSS, version 25,
IBM, Armonk, New York) and Statistical Analysis Software (SAS) was used for data cleaning and analysis. The
data were analyzed by independent statisticians: O.C. and
E.P. for the derivation cohort and C.A. and M.Y. for the
validation cohort. Descriptive statistical analyses were
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obtained for all included study variables and are summarized in Supplementary Table 1. Categorical variables are
expressed as frequency or percentage, whereas continuous
variables are presented as mean and standard deviation or
median and interquartile range based on the normality of
the data. First, univariate analysis was performed by using
χ2 test or Fisher exact test for categorical variables and the
T-test or the Mann–Whitney U test for continuous variables.
Multivariate logistic regression analysis using the backward
Wald’s method was then performed to identify the significant variables to be included in the CRI to predict the primary outcome. Different groups among the CRI scores were
compared using χ2 test for categorical variables and analysis of variance or Kruskal Wallis tests for continuous variables based on the normality of the data. Then, the time-toevent analysis was performed using Kaplan–Meier curves,
where significance was calculated using the log-rank test. A
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receiver-operating characteristics (ROC) curve was added to
address the discriminatory power of the CRI, and the area
under the ROC curve was reported. Statistical analyses were
considered significant if P < 0.05.

Validation cohort
The newly developed index was validated with the MICOVID19 database. The MI-COVID-19 database is a statewide multiple health system collaborative quality initiative (CQI) that was sponsored by Blue Cross Blue Shield
of Michigan and Blue Care Network. The aim of this initiative was to improve the quality of hospitalized patients
with COVID-19. The database includes 38 hospitals across
the state of Michigan. The median bed size is 391 (IQR:

A

AUC 0.828 (0.799-0.857), p<0.001

B.
1.0

0.8

Sensitivity

Fig. 1  A The discriminatory
power for the COVID-19 risk
index (CRI) within the derivation (A) and validation (B)
cohorts by receiver-operating
characteristic (ROC) area under
the curve (AUC)

250–537), 81% are non-profit, and 93% self-identify as
teaching hospitals. Patients admitted at the Henry Ford Hospital system (used as a derivation cohort) were excluded.
The same inclusion and exclusion criteria as the derivation
cohort were applied. Validation and the creation of ROC
curves were performed through logistic regression modeling.
Calibration was performed in a similar fashion. Each patient
was assessed for the number of significant factors (as defined
in the original cohort) that were affecting them at the time of
admission and assigned a score. The total score compared to
the outcome was first assessed for each patient as an unadjusted rate. Logistic regression was then used to estimate the
predicted probabilities of having the outcome compared to
the total score. These predicted probabilities were used to
calculated adjusted rates of the outcome within each score

0.6

0.4

AUC 0.735 (0.709, 0.761)
0.2

0.0

0.0

0.2

0.4

0.6

1-Speciicity

0.8

1.0
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category. Finally, the unadjusted rates were compared to the
adjusted rates (Fig. 1).

Results
We reviewed the charts of a total of 1024 patients admitted
between March 8 and May 1, 2020. Of those, three were
transferred in or out of our institution, and one presented
with cardiac arrest and were therefore excluded. A total
of 1020 patients were included in the final analysis for
the derivation cohort. Table 1 shows the baseline clinical
characteristics of the overall derivation cohort and is categorized into those with or without the primary outcome
of death or need for mechanical ventilation. Characteristics included demographics, symptoms on presentation,
comorbid conditions, medications, and laboratory/imaging
data.

Using the significant univariate predictors, a multivariate logistic regression analysis was performed to identify the independent predictors of our primary outcome.
Variables included in the multivariate regression model
included: age ≥ 65, gender, body mass index, hypertension, smoking history, diabetes mellitus, cardiovascular
disease, chronic obstructive pulmonary disease, history of
immunosuppression, anemia, chronic kidney disease, ferritin ≥ 600 (ng/mL), troponin > 18 (ng/dL), D-dimer ≥ 1.1
(µg/mL), creatinine phosphokinase ≥ 10 (IU/L), lactate
dehydrogenase ≥ 340 (IU/L), and S
 pO2:FiO 2 categories
(Table 1). Of these variables, the significant multivariate predictors were age ≥ 65 years, chronic obstructive
pulmonary disease, chronic kidney disease, cerebrovascular disease, initial D-dimer > 1.1 µg/mL, platelet
count < 150 K/µL, and severity of SpO2:FiO2 ratio (Derivation cohort: Table 2, Validation cohort: Table 4). These
variables were used to derive the CRI.

Table 2  Multivariable predictors of death or intubation in the COVID-19 risk index (CRI) derivation cohort
CRI predictors

Univariate regression
OR (95% CI), P value

Multivariate regression
AdjOR (95% CI), P value

Points

Age (≥ 65 years)
Thrombocytopenia < 150 K
D-dimer initial ≥ 1.1 (µg/mL)
Chronic kidney disease
Chronic obstructive pulmonary disease
Cerebrovascular disease
SpO2/FiO2 ratio > 300 to ≤ 400
SpO2/FiO2 ratio > 200 to ≤ 300
SpO2/FiO2 ratio ≤ 200

3.20 (2.35–4.36), < 0.001
3.20 (2.35–4.36), < 0.001
3.61 (2.53–5.15), < 0.001
3.03 (2.24–4.10), < 0.001
2.48 (1.63–3.78), < 0.001
3.83 (2.40–6.10), < 0.001
1.96 (1.22–3.15), 0.006
4.54 (2.94–7.01), < 0.001
22.11 (13.35–36.61), < 0.001

1.76 (1.17–2.63), 0.006
1.78 (1.15–2.76), 0.010
1.97 (1.28–3.03), 0.002
2.24 (1.49–3.36), < 0.001
1.77 (1.04–3.00), 0.034
3.06 (1.71–5.47), < 0.001
2.16 (1.25–3.73), 0.006
4.82 (2.92–7.97), < 0.001
12.44 (6.62–23.38), < 0.001

+1
+1
+1
+1
+1
+1
+1
+2
+3

Multivariable predictors of the primary outcome, mechanical ventilation or death, in the COVID-19 risk index (CRI) derivation cohort. Variable controlled for: Age ≥ 65 years, Hypertension, Diabetes Mellitus, Immunosuppressed state, Chronic Obstructive Pulmonary Disease, Chronic
Kidney Disease, Coronary Artery Disease, Atrial fibrillation/ flutter, Cerebrovascular Disease, Chronic Hypoxic Respiratory Failure, Smoking
History, SPO2:FiO2 Category, Hypotension (MAP < 65 mmHg), LDH ≥ 700, D-dimer ≥ 1.1, Cardiac Injury, thrombocytopenia < 150 K, Anemia
(Hb < 12), Ferritin ≥ 700. The CRI score is computed by adding the points allocated to CRI predictor with a minimum of 0 and maximum of 10
total points

Table 3  Primary outcome within different score groups within CRI categories
Variable

COVID risk index—No/total (%) – derivation cohort
(mechanical ventilation or mortality)
COVID risk index—No/total (%)—derivation cohort
(inpatient mortality only)
COVID risk index—No/total (%)—validation cohort
(mechanical ventilation or mortality)
COVID risk index—No/total (%)—validation cohort
(inpatient mortality only)
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Score
0

1

2

3

4

5

6

≥7

0/118
(0%)
0/118
(0%)
33/381
(9%)
11/381
(3%)

14/233
(6%)
9/233
(4%)
73/487
(15%)
54/487
(11%)

32/231
(14%)
23/231
(11%)
112/386
(29%)
95/386
(25%)

45/188
(24%)
32/188
(17%)
80/250
(32%)
64/250
(26%)

69/153
(45%)
51/153
(33%)
92/172
(53%)
74/172
(43%)

46/63
(73%)
37/63
(59%)
55/82
(67%)
45/82
(55%)

26/30
(87%)
21/30
(70%)
19/30
(63%)
15/30
(50%)

4/4
(100%)
4/4
(100%)
11/11
(100%)
10/11
(91%)

COVID‑19 risk index (CRI): a simple and validated emergency department risk score that predicts…
Fig. 2  Calibration plot

Calibration Plot

100%

100%

86%

Percent of Patients with Outcome

90%
77%

80%
67%65%

70%
60%

63%

53%
51%

50%
40%
29%
25%

30%
20%
10%
0%

9% 9%

0

37%
32%

15%16%

1

2

3

4

5

6

>=7

Total Score
Observed Mean

Patients’ CRI scores were calculated according to the sum
of CRI points they had on presentation to the ED (Table 2).
The incidence of the primary outcome increased steadily
with higher CRI scores (Table 3) in both the derivation and
validation cohorts (area under ROC: 0.84 [derivation] and
vs. 0.74 [validation]).
To validate our index, we analyzed the predictive capability of the CRI in an external cohort of 1799 sampled hospitalized patients. Supplementary Table 1 includes the baseline characteristics of the validation cohort. The validation
cohort had a similar trend and distribution of the primary
endpoint according to the CRI model (Table 3). The calibration plot (Fig. 2) reveals a close adherence between the
observed and expected primary outcomes within the validation cohort.

Table 4  Univariate odds ratio
of score components within the
validation cohort

Predicted Mean

Discussion
We describe a new risk predictive model for patients admitted with COVID-19 using easily acquired data elements in
the ED. The CRI predicts the need for mechanical ventilation or inpatient death.
Although certain clinical characteristics are associated
with increased mortality in COVID-19 [11], a validated
disease-specific model to assess risk at the time of presentation to the ED is lacking. The CRI encompasses seven
variables that were independently associated with the need
for mechanical ventilation or death in patients hospitalized
with COVID-19. Patients score points for age ≥ 65 years,
chronic obstructive pulmonary disease, chronic kidney disease, cerebrovascular disease, initial D-dimer > 1.1 µg/mL,
platelet count < 150 K/µL, and severity of SpO2:FiO2 ratio
(Table 2). All the above variables have been shown to be
associated with worse outcomes in patients with COVID-19

CRI Predictors

Univariate regression
OR (95% CI), P value

Multivariate regression
OR (95% CI), P value

Age (≥ 65 years)
Thrombocytopenia < 150 K
D-dimer initial ≥ 1.1 (µg/mL)
Chronic kidney disease
Chronic obstructive pulmonary disease
Cerebrovascular disease
SpO2/FiO2 ratio > 300 to ≤ 400
SpO2/FiO2 ratio > 200 to ≤ 300
SpO2/FiO2 ratio ≤ 200

2.56 (2.05–3.18), < 0.001
1.11 (0.88–1.39), 0.40
1.70 (1.26–2.29), < 0.001
1.67 (1.33–2.10), < 0.001
1.72 (1.27–2.31), < 0.001
1.69 (1.25–2.28), < 0.001
1.50 (1.16–1.95), 0.002
7.37 (4.01–13.56), < 0.001
13.32 (8.81–20.13), < 0.001

1.97 (1.54–2.53), < 0.001
1.19 (0.92–1.55), 0.19
1.25 (0.89–1.77), 0.19
1.35 (1.04–1.75), 0.03
0.94 (0.66–1.34), 0.74
1.34 (0.96–1.88), 0.09
2.12 (1.59–2.82), < 0.001
10.16 (5.40–19.09), < 0.001
16.97 (11.01–26.16), < 0.001

*SpO2/FiO2 ratio Reference =  > 400
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[12–14]. However, not all variables were shown to be independently associated with the primary outcome.
There have been other clinical risk predictive models
used to assist with decision-making [7, 15–17], but the CRI
offers several advantages. The variables are objective and
easily obtained at the time of presentation, and the scoring
system is simple. A low CRI was associated with a lower
risk for mechanical ventilation or death in both the derivation and validation cohorts, and the rates increased with
higher scores. The score can assist in the triage of patients
with lower scores to units with lower provider-to-patient
ratios given the low likelihood for mechanical ventilation
or death. Conversely, a higher score confers an increased risk
of mechanical ventilation or death, mandating closer monitoring during admission (Table 3). In comparison to other
score models, the CRI was validated against a larger and
more heterogeneous population. It also utilized data from
a more predictable time point (admission) compared to the
variable time points utilized by other models.
Temporal trends indicate that the demographics and the
approach to the care of COVID-19 patients have changed
as the disease has evolved and clinical and research experience accumulates. The initial aggressive approach to initiate mechanical ventilation has tempered. While changing
practice variations can challenge the applicability of risk
models, the CRI uses objective and plausible metrics that
have a strong association with the underlying disease state
and we believe will maintain relevance (Table 4).
During a pandemic, and especially in areas of high case
density, clinical tools and prediction models can aid in
appropriate patient triage and resource allocation. The CRI
is a useful tool that weighs the chance of survival with risk
for ICU care, mechanical ventilation, or death, allowing for
objective and efficient ED triage and management of patients
admitted with COVID-19. We, therefore, suggest obtaining
the CRI on admission for such patients.

Limitations
Our study is retrospective and therefore is subject to limitations. Our cohort was limited to hospitalized patients and
cannot be generalized to all patients diagnosed with COVID19 as the model captures an earlier state of patient demographics, disease management, outcomes, and vaccination.
Future prospective and multicenter studies should re-assess
the CRI to further determine generalizability as the disease
patterns change and new variants are discovered.
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Conclusions
In conclusion, the CRI is an important tool that can guide
early triage, inform treatment strategies, and empower physician decision-making during the COVID-19 pandemic.
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